May 31, 2023
Bayer Corp. is pushing back against a bid for attorney fees by the former legal team of a whistleblower who secured a more than $40 million settlement in suits in New Jersey and Minnesota alleging the company downplayed the risks of some of its drugs, saying their requests for millions in fees should be either substantially reduced or nixed altogether.
January 09, 2023
The law firm that won a $46 million False Claims Act settlement against Bayer last September is seeking $2.2 million in attorney fees, emphasizing the uphill battle it took on in litigating the technically complicated case and the risk it assumed by fronting over $100,000 in litigation costs.
September 02, 2022
The U.S. Department of Justice on Friday announced that it had reached a $40 million settlement with Bayer AG to end allegations that the company violated the False Claims Act over three of its drugs, ending years of litigation in two whistleblower suits.
October 17, 2018
A Minnesota federal court judge has kept alive a long-running False Claims Act suit alleging that Bayer AG misled the U.S. Department of Defense about the risks of its now-defunct cholesterol drug Baycol, finding that the relator had presented enough evidence to show that she had direct knowledge of the alleged fraud.
July 19, 2012
A Minnesota federal judge on Thursday tossed a suit from a former employee accusing Bayer AG of misrepresenting the risks of its cholesterol drug Baycol — which was pulled after 31 deaths were linked to its use — and causing false claims to be submitted to Medicare.